Filing Details
- Accession Number:
- 0001628280-21-000148
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-06 08:25:07
- Reporting Period:
- 2021-01-05
- Accepted Time:
- 2021-01-06 08:25:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501697 | X4 Pharmaceuticals Inc | XFOR | Biological Products, (No Disgnostic Substances) (2836) | 273181608 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1769914 | Paula Ragan | C/O X4 Pharmaceuticals, Inc. 61 North Beacon Street, 4Th Floor Boston MA 02134 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-01-05 | 2,400 | $7.00 | 277,723 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
